Request an Appointment



Contact us with Questions

Expand Content

Fetnat Fouad-Tarazi, MD


Fetnat Fouad-Tarazi, MD
Department: College of Medicine
Retired Staff
Location: Cleveland Clinic Main Campus
Mail Code JJ5
9500 Euclid Avenue
Cleveland, OH 44195
Adults Only

Biographical Sketch

Fetnat Mahmoud Fouad Tarazi, MD, is Head of the Cleveland Clinic’s Hemodynamic and Neuroregulation Lab in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Cardiology, EP Imaging Section. She holds joint appointments in the Department of Nuclear Medicine and the Department of Molecular Cardiology. Dr. Fouad, who specializes in syncope, hypertension and cardiovascular disease, is board-certified in internal medicine and cardiovascular disease.

Dr. Fouad received her medical degree from the Cairo University Faculty of Medicine in Egypt. She completed her internship and residency (in cardiology) at the Kasr El Aini Hospital at Cairo University, where she became Senior Registrar. She was a Special Fellow at Cleveland Clinic in the Division of Research. She also received the International Traveling Fellowship from Cleveland Clinic and a Senior Fellowship from the American Heart Association.

She is a Fellow of the American College of Cardiology, the Central Society for Clinical Research, and the Council for High Blood Pressure Research. She is a member of the American College of Physicians, the American Society of Clinical Pharmacology, the American Medical Women’s Association, Inc, the American Medical Association, the American Autonomic Society, the American Federation for Clinical Research and the Cardiac Muscle Society.

Dr. Fouad is a reviewer for numerous publications including the American Journal of Cardiology, the Annals of Internal Medicine, Circulation, and Cardiovascular Drugs, to name a few. She is on the editorial board of the American Journal of Noninvasive Cardiology and Hypertension. She grades abstracts for the American College of Cardiology, the North American Society for Pacing and Electrophysiology and the American Heart Association

She is currently involved in several research projects that focus on blood pressure regulation in the supine posture and during Upright posture [changes induced by effect of gravity and acceleration/deceleration]. Some of the studies in hypertensive patients focus on how the use of different medicines can, among other things, help lower patients' blood pressure and fight heart failure. Other studies in syncope focus on understanding the mechanisms of postural dizziness/light headedness and syncope, the predictors to precipitation of events, and the establishment of contemporary approaches to diagnose and treat this condition.

Dr. Fouad has authored or co-authored numerous articles and abstracts in leading medical journals including Hypertension, Anesthesiology, the Journal of Nuclear Medicine, the American Journal of Cardiology, Annals of Internal Medicine and Circulation.

Professional Highlights

  • Pioneered evaluation of syncope by laboratory assessment of the circulation and autonomic nervous system. As a result, a nationwide interest developed, which was to the best advantage of these patients.

Education & Fellowships

Fellowship - Cleveland Clinic
Cleveland, OH USA
Residency - Cairo University Hospital
Cairo Egypt
Internship - Cairo University Hospital
Cairo Egypt
Medical School - University of Cairo Faculty of Medicine
Cairo Egypt

Specialty Interests

Autonomic Nervous System Function, Dizziness, Dysautonomia, Fainting, Near Syncope, Orthostatic Hypotension, Syncope, Blood Volume Test, Head Upright Tilt Test

Awards & Honors

  • Cleveland Clinic International Traveling Fellowship Award, 1978
  • Cleveland Clinic Lower Prize for Clinical Research,1978
  • Henry Christian Award for Excellence in Research,1993
  • Cover story in Cleveland MD News, April, 2002
  • Received research funding from NIH and pharmaceutical companies as well as CCF-RPC
  • Received individual gifts/donations to support research from Pfizer, Daxor, Burks County Community Foundation, Reading, Pa.

Additional Training

  • Sabbatical in Dallas to learn MSNA technique for direct evaluation of sympathetic nervous system function for research application
  • Innovation visit to NIH to promote use of cardiac imaging techniques and neuropharmacologic procedures for state of the art evaluation of autonomic nervous system function in humans
  • Approved CLIA for blood volume measurements in our syncope lab for evaluation of various cardiovascular problems
  • Training in nuclear cardiac first pass and MUGA procedures at Cleveland Clinic and via International Traveling Fellowship Award; also training in requirements related to radioisotope use and safety applications in humans
  • Initiation of the Langendorff isolated heart technique at ccf for basic research in cardiac physiology

Innovations & Patents

  • Development of Non-Invasive Nuclear Hemodynamic Method: This method allows outpatient evaluation and also can be repeated at intervals for follow-up as needed to assess response to treatment and assessment of disease progression
  • Expansion of autonomic reflex testing to include combination of vascular reactivity measures along with procedures based on bp and hr; this addition allows for more accurate diagnosis by characterization of the cause of bp change in response to an intervention


  • American College of Cardiology
  • American Heart Association
  • Heart Rhythm Society
  • Society of Nuclear Medicine, American Society of Nuclear Cardiology
  • American Autonomic Society

Treatment & Services

  • Autonomic Reflex Test
  • Blood Tests
  • Blood Volume Test
  • Clinical Trials
  • Heart Rate Variability Test
  • Hemodynamic Evaluation
  • Nuclear Blood Volume Test
  • Nuclear Hemodynamic Blood Flow Test
  • Tilt Test
  • Vascular Reactivity Tests

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 8/4/2014, Dr. Fouad-Tarazi has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • Arabic
  • English
  • French